From gynaecology to obstetrics, from breast cancer treatments to menopause research: the distinct medical needs of female patients are manifold. But also in many other areas of research, diagnostics and therapy, the awareness of women requiring different approaches than male patients is dawning.
A cardiac rehabilitation programme tailored especially to women could help address specific needs of female patients with conditions such as heart failure, arrhythmia or after cardiothoracic surgery.
A large Danish study shows that women with endometriosis use more anxiety and depression medication than others – as early as ten years before they receive their diagnosis.
Severe back pain and fractures may hint at pregnancy- and lactation-associated osteoporosis (PLO). A new publication aims to help healthcare professionals identify and treat women with PLO.
A promising predictive model could help women calculate their personal risk for breast cancer, based on non-genetic, genetic and mammographic risk factors, and greatly improve early detection efforts.
Migraines, digestive problems, anxiety, and depression can be part of endometriosis. New research reinforces the idea that the disease extends far beyond its traditional gynecological manifestations.
Adenomyosis can cause heavy menstrual bleeding, severe pain, and pregnancy and fertility complications. New research could help pave the way for more targeted, less invasive treatments.
A pilot study shows that immunotherapy may enable stimulation of egg maturation in women with premature menopause. Three out of ten women gave birth to healthy babies following the treatment.
A new study uncovers new factors associated with ICP, a pregnancy-related liver disease. The findings open up new avenues for research into maternal health and pregnancy-related liver diseases.
Imaging pregnant women with acute abdominal pain remains a significant clinical challenge – not only because of concerns about the impact on the unborn child, but also due to the anatomical changes that can obscure diagnosis. At the European Congress of Radiology (ECR) in Vienna, radiologists Vikas Shah and Charis Bourgioti examined the protocols for safe imaging in pregnancy and the management…
Fragmented care pathways, persistent data gaps and a ‘postcode lottery’ of services continue to undermine the quality of healthcare for women across the United Kingdom. At the HETT25 conference in London, a panel of experts from primary and secondary care, research, femtech and digital health innovation discussed how integrated care models and digital tools can reshape outcomes – and why…
Polycystic Ovary Syndrome (PCOS) is being renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) – but will it help those it affects? Experts argue what else needs to change to make a difference.
Many women with myasthenia gravis choose not to have children due to fear that the disease will get worse during or after pregnancy. Now, a study investigated the connection to the autoimmune disease.
Heart disease risk has been found to increase in women with polycystic ovary syndrome (PCOS), even in those with normal weight, according to new research.
Endometriosis affects up to one in ten women and girls of reproductive age, but for many, the path to diagnosis is both long and complex. Now, two new studies explain the diagnostic challenges in primary care.
After 15 years of HPV vaccination programmes across Europe, growing evidence confirms their long-term effectiveness. A new report highlights steady progress in cancer prevention efforts.
Repeated menstrual cycles may do more than trigger endometriosis – they may rewire the brain, a new study finds. Recurring inflammation can sensitize the nervous system, driving lasting pain.
As women age, their breast tissue goes through major changes, with the most dramatic changes at menopause, but also during pregnancy and childbirth. A map reveals the impact on breast cancer.
Women are more likely to survive cancer than men but face a higher risk of serious and adverse side effects from treatment, according to a new international study.
Study shows women with stage IV breast cancer detected through screening have a 60% chance of survival ten years after diagnosis – compared to under 20% for those not detected through screening.
